RT @Eurosurveillanc: New technology offers a variety of cost-effective rapid testing kits to improve access to testing
This perspective explores upsides, implications & necessary steps for the use of platforms for multi-disease testing for #TB #HIV #HCV #STI
⬇️
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.29.2100930
#EuroTestWeek